查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1400999

肥大细胞肿瘤治疗市场，按药物类别、给药途径、配销通路、国家和地区 - 2023-2030 年行业分析、市场规模、市场份额和预测

Mast Cell Tumors Treatment Market, By Drug Class, By Route of Administration, By Distribution Channel, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 79 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2022 年，肥大细胞肿瘤治疗市场规模达 51 亿美元，2023 年至 2030 年CAGR为 3.6%。

肥大细胞肿瘤治疗市场-市场动态

兽医肿瘤学日益重视精准医疗推动市场需求

随着对 MCT 发生和进展的遗传和分子机制了解的加深，标靶治疗变得越来越可能。这种个人化方法根据肿瘤的个别特征客製化药物，最大限度地提高疗效，同时最大限度地减少负面影响。在个体肿瘤的遗传和分子分析的引领下，创新标靶药物和免疫疗法的开发正在获得关注。这种驱动因素​​不仅可以改善治疗效果，还可以改善患有 MCT 和其他恶性肿瘤的狗的整体生活品质。

肥大细胞肿瘤治疗市场 - 关键见解

根据我们的研究分析师分享的分析，全球肥大细胞肿瘤治疗市场预计在预测期（2023-2030）每年将以 3.6% 左右的CAGR成长

由于兽医肿瘤学中对精准医疗的日益重视，肥大细胞肿瘤治疗产业预计将以显着的速度成长。

根据药物类别细分，预计肾上腺素将在 2022 年显示最大的市场份额

根据给药途径细分，注射剂是 2022 年领先的药物类别

按地区划分，亚太地区是 2022 年领先的收入来源

肥大细胞肿瘤治疗市场-細項分析：

全球肥大细胞肿瘤治疗市场根据药物类别、给药途径、配销通路和地区进行细分。

依药物类别，市场分为四类：抗组织胺、肾上腺素、类固醇、肥大细胞稳定剂。肾上腺素在市场上占据主导地位。由于 MCT 能够产生组织胺，在某些情况下可能会引起严重的过敏反应，因此治疗期间可能需要肾上腺素。作为一种紧急药物，肾上腺素有助于控制 MCT 脱颗粒引起的过敏反应，从而实现更快的干预和更好的患者治疗效果。

依给药途径，市场分为三类：口服、注射、外用。注射剂产业在市场中占据主导地位，并可能在预测期内保持其主导地位。由于多种原因，注射药物对于治疗肥大细胞肿瘤的需求量很大。它们用于在 MCT 脱粒引起的严重过敏反应的情况下提供化疗、标靶治疗和紧急药物（例如肾上腺素），从而为这种困难类型的癌症提供成功和快速的治疗。

肥大细胞肿瘤治疗市场 - 地理洞察

从地理来看，该市场广泛分布于北美、拉丁美洲、欧洲、亚太地区以及中东和非洲地区。这些区域根据开展业务的国家进一步划分。狗的肥大细胞肿瘤（MCT）在亚太地区越来越流行。这种倾向受到多种因素的影响。该地区多个国家宠物拥有率的提高导致兽医服务和治疗市场蓬勃发展。其次，人们对犬类健康问题，尤其是 MCT 等癌症的了解不断增加，促使更多的宠物主人为他们的宠物寻求医疗照护。最后，亚太地区兽医肿瘤学的进步以及越来越多的专业兽医诊所和医院增加了诊断和治疗选择的机会，满足了该地区对有效 MCT 治疗日益增长的需求。

肥大细胞肿瘤治疗市场-竞争格局：

肥大细胞肿瘤 (MCT) 的治疗前景是动态的，有多种因素在起作用。化疗和标靶药物可从 Zoetis、Elanco 和 Merck Animal Health 等领先兽医製药公司获得。此外，专门的兽医癌症中心（例如 PetCure cancer）可以提供复杂的放射治疗。旨在开发新药的研究和开发措施可能会对环境产生影响。製药公司、研究机构和兽医诊所之间的合作促进了 MCT 疗法的进步。随着人们对宠物医疗保健的日益关注，竞争促进了治疗方法的改进，最终帮助犬类 MCT 患者及其家人。

最近的发展：

2023 年5 月，用于非手术皮肤癌和疤痕疙瘩治疗的先进医疗设备的领先供应商Sensus Healthcare Inc. 很高兴地宣布，他们的浅表放射治疗SRT-100 系统在治疗皮肤肥大细胞肿瘤方面显示出令人鼓舞的结果（MCT）在猫咪身上。这项新的限制性研究最近发表在《美国兽医协会杂誌》上，显示了 SRT 疗法的潜在功效和安全性。

目录

第一章：肥大细胞肿瘤治疗市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 按药物类别分類的肥大细胞肿瘤治疗市场片段
    • 依给药途径分類的肥大细胞肿瘤治疗市场片段
    • 按配销通路的肥大细胞肿瘤治疗市场片段
    • 按国家/地区分類的肥大细胞肿瘤治疗市场片段
    • 按地区分類的肥大细胞肿瘤治疗市场片段
  • 竞争洞察

第 3 章：肥大细胞肿瘤治疗主要市场趋势

  • 肥大细胞肿瘤治疗市场驱动因素
    • 市场驱动因素的影响分析
  • 肥大细胞肿瘤治疗市场限制
    • 市场限制影响分析
  • 肥大细胞肿瘤治疗市场机会
  • 肥大细胞肿瘤治疗市场未来趋势

第 4 章：肥大细胞肿瘤治疗产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：肥大细胞肿瘤治疗市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：肥大细胞肿瘤治疗市场格局

  • 2022 年肥大细胞肿瘤治疗市占分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：肥大细胞肿瘤治疗市场 - 依药物类别

  • 概述
    • 按药物类别分類的细分市场份额分析
    • 抗组织胺药
    • 肾上腺素
    • 类固醇
    • 肥大细胞稳定剂

第 8 章：肥大细胞肿瘤治疗市场 - 依给药途径

  • 概述
    • 按给药途径分類的细分市占率分析
    • 口服
    • 注射剂
    • 专题

第 9 章：肥大细胞肿瘤治疗市场 - 按配销通路

  • 概述
    • 按配销通路分類的细分市场份额分析
    • 医院药房
    • 零售药局
    • 药局
    • 网路药局

第 10 章：肥大细胞肿瘤治疗市场 - 依地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 肥大细胞肿瘤治疗北美主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按药物类别）
    • 北美市场规模与预测（按管理途径）
    • 北美市场规模和预测（按配销通路）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 肥大细胞肿瘤治疗欧洲主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模和预测（按药物类别）
    • 欧洲市场规模与预测（按管理途径）
    • 欧洲市场规模和预测（按配销通路）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 肥大细胞肿瘤治疗亚太地区主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模和预测（按药物类别）
    • 亚太地区市场规模与预测（依管理途径）
    • 亚太地区市场规模和预测（按配销通路）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲肥大细胞肿瘤治疗主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按药物类别）
    • 拉丁美洲市场规模与预测（按管理途径）
    • 拉丁美洲市场规模和预测（按配销通路）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 肥大细胞肿瘤治疗中东和非洲主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按药物类别）
    • 中东和非洲市场规模及预测（按管理途径）
    • 中东和非洲市场规模及预测（按配销通路）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 11 章：主要供应商分析 - 肥大细胞肿瘤治疗产业

  • 竞争仪表板
  • 公司简介
    • Zoetis
    • Elanco Animal Health
    • Merck Animal Health
    • Boehringer Ingelheim
    • PetCure Oncology
    • Varian Medical Systems
    • VetDC, Inc.
    • Oasmia Pharmaceutical AB
    • Aratana Therapeutics
    • Rhizen Pharmaceuticals
    • Animal Medical Center
    • Blue Buffalo Foundation
    • Ethos Veterinary Health
    • PetCure Oncology
    • Veterinary Cancer Group

第 12 章：360 度分析师视角

第 13 章：附录

  • 研究方法论
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
Product Code: ANV1963

REPORT HIGHLIGHT

Mast Cell Tumors Treatment Market size was valued at USD 5,100 Million in 2022, expanding at a CAGR of 3.6% from 2023 to 2030.

Mast cell tumors (MCTs) are a kind of cancer that is frequent in dogs. Mast cells, a kind of immune cell implicated in allergic responses and inflammation, are the source of these tumors. MCTs come in a variety of sizes, shapes, and malignancies. Mast cell tumors are normally treated surgically, with the goal of entirely excising the tumor. Additional treatments, such as radiation, chemotherapy, or targeted drugs, may be required in certain circumstances, particularly for aggressive or metastatic tumors. Regular veterinarian check-ups and monitoring are essential for dogs at risk of MCTs since early discovery and timely treatment are critical for a favorable outcome.

Mast Cell Tumors Treatment Market- Market Dynamics

Increasing emphasis on precision medicine in veterinary oncology propel market demand

Targeted therapy becomes increasingly possible as knowledge of the genetic and molecular mechanisms that contribute to MCT genesis and progression improves. This personalized method tailor's medicines to the tumor's individual features, maximizing effectiveness while minimizing negative effects. The development of innovative targeted medications and immunotherapies is gaining traction, led by genetic and molecular analysis of individual tumours. This driver improves not just treatment results but also the entire quality of life for dogs suffering from MCTs and other malignancies.

Mast Cell Tumors Treatment Market- Key Insights

As per the analysis shared by our research analyst, the global Mast Cell Tumors Treatment market is estimated to grow annually at a CAGR of around 3.6% over the forecast period (2023-2030)

The Mast Cell Tumors Treatment industry is projected to grow at a significant rate due to increasing emphasis on precision medicine in veterinary oncology.

Based on Drug Class segmentation, Epinephrine was predicted to show maximum market share in the year 2022

Based on Route of Administration segmentation, Injectables was the leading Drug Class in 2022

On the basis of region, Asia Pacific was the leading revenue generator in 2022

Mast Cell Tumors Treatment Market- Segmentation Analysis:

The Global Mast Cell Tumors Treatment Market is segmented on the basis of Drug Class, Route of Administration, Distribution Channel, and Region.

The market is divided into four categories based on Drug Class: Antihistamines, Epinephrine, Steroids, Mast-cell stabilizers. The Epinephrine dominates the market. Because MCTs have the ability to produce histamines, which may cause severe allergic responses in certain circumstances, epinephrine need may occur during therapy. As an emergency medication, epinephrine aids in the management of anaphylactic responses caused by MCT degranulation, allowing for faster intervention and better patient outcomes.

The market is divided into three categories based on Route of Administration: Oral, Injectables, Topical. The Injectables sector dominates the market and is likely to maintain its dominance during the forecast period. Injectable medicines are in high demand for the treatment of mast cell tumors for a variety of reasons. They are used to deliver chemotherapy, targeted treatments, and emergency medications like as epinephrine in situations of severe allergic responses induced by MCT degranulation, providing successful and speedy treatment of this difficult type of cancer.

Mast Cell Tumors Treatment Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. Mast cell tumors (MCTs) in dogs are becoming more popular in the Asia-Pacific area. This tendency is influenced by a variety of things. Increased pet ownership rates in several nations around the area have resulted in a burgeoning market for veterinarian services and treatments. Second, increased knowledge of canine health issues, particularly cancers such as MCTs, has prompted more pet owners to seek medical attention for their pets. Finally, advances in veterinary oncology and an increasing number of specialized veterinary clinics and hospitals in the Asia-Pacific area have enhanced access to diagnostic and treatment choices, satisfying the region's growing need for effective MCT treatments.

Mast Cell Tumors Treatment Market- Competitive Landscape:

The therapy landscape for mast cell tumors (MCTs) is dynamic, with various elements at work. Chemotherapy and targeted medicines are available from leading veterinary pharmaceutical firms such as Zoetis, Elanco, and Merck Animal Health. Furthermore, sophisticated radiation therapy are available at specialized veterinary cancer centers such as PetCure cancer. Research and development initiatives targeted at developing novel medicines can have an impact on the environment. Collaboration among pharmaceutical firms, research institutions, and veterinary clinics promotes MCT therapy advancement. With a rising focus on pet healthcare, competition promotes therapeutic improvements, eventually helping canine MCT sufferers and their families.

Recent Developments:

In May 2023, Sensus Healthcare Inc., a leading provider of sophisticated medical devices for non-surgical skin cancer and keloid scar treatment, is pleased to announce that their superficial radiation therapy SRT-100 system has shown encouraging results in treating Cutaneous Mast Cell Tumours (MCTs) in cats. This new restricted research, which recently appeared in the Journal of the American Veterinary Medical Association, shows the potential efficacy and safety of SRT therapy.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL MAST CELL TUMORS TREATMENT MARKET KEY PLAYERS

  • Zoetis
  • Elanco Animal Health
  • Merck Animal Health
  • Boehringer Ingelheim
  • PetCure Oncology
  • Varian Medical Systems
  • VetDC, Inc.
  • Oasmia Pharmaceutical AB
  • Aratana Therapeutics
  • Rhizen Pharmaceuticals
  • Animal Medical Center
  • Blue Buffalo Foundation
  • Ethos Veterinary Health
  • PetCure Oncology
  • Veterinary Cancer Group

GLOBAL MAST CELL TUMORS TREATMENT MARKET, BY DRUG CLASS

  • Antihistamines
  • Epinephrine
  • Steroids
  • Mast-cell stabilizers

GLOBAL MAST CELL TUMORS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION

  • Oral
  • Injectables
  • Topical

GLOBAL MAST CELL TUMORS TREATMENT MARKET, BY DISTRIBUTION CHANNEL

  • Hospital Pharmacies
  • Retail Pharmacies
  • Drug Stores
  • Online Pharmacies

GLOBAL MAST CELL TUMORS TREATMENT MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Mast Cell Tumors Treatment Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Mast Cell Tumors Treatment Market Snippet by Drug Class
    • 2.1.2. Mast Cell Tumors Treatment Market Snippet by Route of Administration
    • 2.1.3. Mast Cell Tumors Treatment Market Snippet by Distribution Channel
    • 2.1.4. Mast Cell Tumors Treatment Market Snippet by Country
    • 2.1.5. Mast Cell Tumors Treatment Market Snippet by Region
  • 2.2. Competitive Insights

3. Mast Cell Tumors Treatment Key Market Trends

  • 3.1. Mast Cell Tumors Treatment Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Mast Cell Tumors Treatment Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Mast Cell Tumors Treatment Market Opportunities
  • 3.4. Mast Cell Tumors Treatment Market Future Trends

4. Mast Cell Tumors Treatment Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Mast Cell Tumors Treatment Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Mast Cell Tumors Treatment Market Landscape

  • 6.1. Mast Cell Tumors Treatment Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Mast Cell Tumors Treatment Market - By Drug Class

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Drug Class, 2022 & 2030 (%)
    • 7.1.2. Antihistamines
    • 7.1.3. Epinephrine
    • 7.1.4. Steroids
    • 7.1.5. Mast-cell stabilizers

8. Mast Cell Tumors Treatment Market - By Route of Administration

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Route of Administration, 2022 & 2030 (%)
    • 8.1.2. Oral
    • 8.1.3. Injectables
    • 8.1.4. Topical

9. Mast Cell Tumors Treatment Market - By Distribution Channel

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Distribution Channel, 2022 & 2030 (%)
    • 9.1.2. Hospital Pharmacies
    • 9.1.3. Retail Pharmacies
    • 9.1.4. Drug Stores
    • 9.1.5. Online Pharmacies

10. Mast Cell Tumors Treatment Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Mast Cell Tumors Treatment Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Mast Cell Tumors Treatment Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Mast Cell Tumors Treatment Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Mast Cell Tumors Treatment Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Mast Cell Tumors Treatment Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Mast Cell Tumors Treatment Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Zoetis
    • 11.2.2. Elanco Animal Health
    • 11.2.3. Merck Animal Health
    • 11.2.4. Boehringer Ingelheim
    • 11.2.5. PetCure Oncology
    • 11.2.6. Varian Medical Systems
    • 11.2.7. VetDC, Inc.
    • 11.2.8. Oasmia Pharmaceutical AB
    • 11.2.9. Aratana Therapeutics
    • 11.2.10. Rhizen Pharmaceuticals
    • 11.2.11. Animal Medical Center
    • 11.2.12. Blue Buffalo Foundation
    • 11.2.13. Ethos Veterinary Health
    • 11.2.14. PetCure Oncology
    • 11.2.15. Veterinary Cancer Group

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data Route of Administrations
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Mast Cell Tumors Treatment Market: Drug Class Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Drug Class
  • TABLE Global Mast Cell Tumors Treatment Market, by Drug Class 2018-2030 (USD Million)
  • TABLE Mast Cell Tumors Treatment Market: Route of Administration Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Route of Administration
  • TABLE Global Mast Cell Tumors Treatment Market, by Route of Administration 2018-2030 (USD Million)
  • TABLE Mast Cell Tumors Treatment Market: Distribution Channel Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Distribution Channel
  • TABLE Global Mast Cell Tumors Treatment Market, by Distribution Channel 2018-2030 (USD Million)
  • TABLE Mast Cell Tumors Treatment Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Mast Cell Tumors Treatment Market, by Region 2018-2030 (USD Million)
  • TABLE North America Mast Cell Tumors Treatment Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Mast Cell Tumors Treatment Market, by Drug Class, 2018-2030 (USD Million)
  • TABLE North America Mast Cell Tumors Treatment Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE North America Mast Cell Tumors Treatment Market, by Distribution Channel, 2018-2030 (USD Million)
  • TABLE Europe Mast Cell Tumors Treatment Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Mast Cell Tumors Treatment Market, by Drug Class, 2018-2030 (USD Million)
  • TABLE Europe Mast Cell Tumors Treatment Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Europe Mast Cell Tumors Treatment Market, by Distribution Channel, 2018-2030 (USD Million)
  • TABLE Asia Pacific Mast Cell Tumors Treatment Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Mast Cell Tumors Treatment Market, by Drug Class, 2018-2030 (USD Million)
  • TABLE Asia Pacific Mast Cell Tumors Treatment Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Asia Pacific Mast Cell Tumors Treatment Market, by Distribution Channel, 2018-2030 (USD Million)
  • TABLE Latin America Mast Cell Tumors Treatment Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Mast Cell Tumors Treatment Market, by Drug Class, 2018-2030 (USD Million)
  • TABLE Latin America Mast Cell Tumors Treatment Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Latin America Mast Cell Tumors Treatment Market, by Distribution Channel, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Mast Cell Tumors Treatment Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Mast Cell Tumors Treatment Market, by Drug Class, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Mast Cell Tumors Treatment Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Mast Cell Tumors Treatment Market, by Distribution Channel, 2018-2030 (USD Million)